SEARCH RESULTS FOR: ("Make Dominican School of Philosophy")(70002 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

Bulk pack
QIAGEN SCIENCES INC.
1
In Commercial Distribution

  • 14053228002144 ()
  • 04053228002147 ()
T05900301

  • Interferon gamma release IVD, reagent
No Description
QIAGEN SCIENCES INC.
1
In Commercial Distribution

  • 14053228002137 ()
  • 04053228002130 ()
5970405

  • Interferon gamma release IVD, reagent
QF-TB Gold Blood collection tubes - Dispenser Pack (25 single patient packs)
QIAGEN SCIENCES INC.
1
In Commercial Distribution

  • 14053228002120 ()
  • 04053228002123 ()
5970403

  • Interferon gamma release IVD, reagent
HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals.
FIDIA FARMACEUTICI SPA
FID185704
Not in Commercial Distribution

  • M71389122049663SAM1 ()
  • M71389122049663SAM0 ()

  • Total Volume: 3 Milliliter
FID185704

  • Synovial fluid supplementation medium
HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals.
FIDIA FARMACEUTICI SPA
89122-0496-63
Not in Commercial Distribution

  • M71389122049663A16 ()
  • M71389122049663 ()

  • Total Volume: 3 Milliliter
89122-0496-63

  • Synovial fluid supplementation medium
No Description
EAGLE SPRINGS ENTERPRISES LLC
NA
Not in Commercial Distribution

  • 00866394000213 ()
  • 10866394000210 ()


  • Synovial fluid supplementation medium
No Description
EAGLE SPRINGS ENTERPRISES LLC
Hylan GF-20
Not in Commercial Distribution

  • 00864223000212 ()
  • 10864223000219 ()


  • Synovial fluid supplementation medium
No Description
EAGLE SPRINGS ENTERPRISES LLC
NA
Not in Commercial Distribution

  • 00864223000205 ()
  • 10864223000202 ()


  • Synovial fluid supplementation medium
Minerva Co2 Canister (5 Pack)
Minerva Surgical, Inc.
MINCo2C
In Commercial Distribution

  • 00862393000148 ()
  • 10862393000145 ()
MINCo2C

  • Inert gas-enhanced endoscopic electrosurgical submucosal lift/resection instrument
Minerva Argon Gas Canister (offered in 5 pack)
Minerva Surgical, Inc.
MINARGC
In Commercial Distribution

  • 00862393000131 ()
  • 10862393000138 ()
MINARGC

  • Inert gas-enhanced endoscopic electrosurgical submucosal lift/resection instrument
< 1 ... 381 382 383 384 385 ... 1000 >